131 related articles for article (PubMed ID: 23663055)
1. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
Wen Q; Zhou L; Chen H; Zhang Y
J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
3. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile.
Bai A; Lu N; Zeng H; Li Z; Zhou X; Chen J; Liu P; Peng Z; Guo Y
J Interferon Cytokine Res; 2010 Jun; 30(6):399-406. PubMed ID: 20187766
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma japonicum eggs modulate the activity of CD4+ CD25+ Tregs and prevent development of colitis in mice.
Mo HM; Liu WQ; Lei JH; Cheng YL; Wang CZ; Li YL
Exp Parasitol; 2007 Aug; 116(4):385-9. PubMed ID: 17433300
[TBL] [Abstract][Full Text] [Related]
6. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
7. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
8. Total alkaloids of Sophora alopecuroides increases the expression of CD4+ CD25+ Tregs and IL-10 in rats with experimental colitis.
Zhou Y; Wang H; Liang L; Zhao WC; Chen Y; Deng HZ
Am J Chin Med; 2010; 38(2):265-77. PubMed ID: 20387224
[TBL] [Abstract][Full Text] [Related]
9. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
11. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
13. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.
Bai A; Ma AG; Yong M; Weiss CR; Ma Y; Guan Q; Bernstein CN; Peng Z
Biochem Pharmacol; 2010 Dec; 80(11):1708-17. PubMed ID: 20797389
[TBL] [Abstract][Full Text] [Related]
14. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
[TBL] [Abstract][Full Text] [Related]
15. CTLA4Ig gene transfer alleviates abortion in mice by expanding CD4+CD25+ regulatory T cells and inducing indoleamine 2,3-dioxygenase.
Li W; Li B; Fan W; Geng L; Li X; Li L; Huang Z; Li S
J Reprod Immunol; 2009 Jun; 80(1-2):1-11. PubMed ID: 19362742
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells.
Dutra RC; Cola M; Leite DF; Bento AF; Claudino RF; Nascimento AF; Leal PC; Calixto JB
Br J Pharmacol; 2011 May; 163(2):358-74. PubMed ID: 21244371
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
